It will now be 3 trading weeks until the CC and af
Post# of 36537
(Total Views: 298)
Posted On: 04/14/2021 12:08:53 PM
It will now be 3 trading weeks until the CC and after that everyone should make a decision for themselves.
The CEO by no means seems to be pursuing the interests of the shareholders, but (that's how it comes across to me) let's play a little grocery store. It's just a disaster with him and the best part about it, he thinks he's doing a good job.
The list of his shortcomings is long and longer. Successes that he can write on the flag ... Nothing.
The vaccine will be available at the earliest next spring (2022) !!! There is no money for other projects, or rather sources of income. Thus, the dilution will continue. ("For the benefit of vaccine development"
As read today, there is now a lot of research into oral vaccinations. Which are not only easier to handle but also have a longer effect. Of course, this is a long way off and who knows, there will be further competition for the numerous vaccine manufacturers.
I'm really amazed how such a person can stay in the saddle, just the Venet. and creek ... disaster unbelievable. And the 1st big deal with the Chinese that wasn't ... Man oh man hands over the helm to a person who understands their craft, because CEO cannot be said about it, sorry but clown is more likely to hit it. (Unfortunately)
Ok, he works for free, hmmm ... stocks NGIO .... it wouldn't be that little.
The CEO by no means seems to be pursuing the interests of the shareholders, but (that's how it comes across to me) let's play a little grocery store. It's just a disaster with him and the best part about it, he thinks he's doing a good job.
The list of his shortcomings is long and longer. Successes that he can write on the flag ... Nothing.
The vaccine will be available at the earliest next spring (2022) !!! There is no money for other projects, or rather sources of income. Thus, the dilution will continue. ("For the benefit of vaccine development"
As read today, there is now a lot of research into oral vaccinations. Which are not only easier to handle but also have a longer effect. Of course, this is a long way off and who knows, there will be further competition for the numerous vaccine manufacturers. I'm really amazed how such a person can stay in the saddle, just the Venet. and creek ... disaster unbelievable. And the 1st big deal with the Chinese that wasn't ... Man oh man hands over the helm to a person who understands their craft, because CEO cannot be said about it, sorry but clown is more likely to hit it. (Unfortunately)
Ok, he works for free, hmmm ... stocks NGIO .... it wouldn't be that little.
(4)
(1)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼